Piper Sandler lowered the firm’s price target on Dyne Therapeutics (DYN) to $48 from $53 following ATM dilution, while keeping an Overweight ...
Andy Laperriere, Piper Sandler head of U.S. policy, joins 'The Exchange' to discuss the questions around the budget ...
Couchbase (NASDAQ:BASE – Get Free Report) had its target price upped by research analysts at Piper Sandler from $21.00 to $22 ...
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...
The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...
Celanese (NYSE:CE – Free Report) had its price target lowered by Piper Sandler from $77.00 to $50.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has an underweight ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Mary Stone as a managing director and co-head of the structured finance group alongside ...
LONDON & NEW YORK, February 19, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ahsan Khan as a managing director along with Jonathan ...
Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm with a market capitalization of $5.1 billion, has demonstrated robust performance and strategic ...
Hosted on MSN52m
Piper Sandler Downgrades Teleflex (TFX)Fintel reports that on February 28, 2025, Piper Sandler downgraded their outlook for Teleflex (NYSE:TFX) from Overweight to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback